Cardiovis is a Sestamibi radiopharmaceutical used for diagnostic purposes to study the heart’s function and blood flow, it is also used for the localisation of hyperfunctioning parathyroid tissue and detection of breast cancer.

Advantages:

  • 10 mL vials
  • High labelling activity, up to 11 GBq
  • Manageable labelling volumes, 1 – 5 ml
  • Long life after labelling, 12 hours